DNTH
DNTH
NASDAQ · Biotechnology

Dianthus Therapeutics Inc

$90.49
+4.46 (+5.18%)
As of Nov 9, 8:25 PM ET ·
DNTH vs Biotechnology Average
Profit Margin
DNTH -7,973.3%
Avg -192.1%

Biotechnology Peers

1013 stocks in sector
Symbol Name Price Change % Market Cap P/E Margin Growth Div Yield Analyst
DNTH Dianthus Therapeutics Inc $90.49 +5.18% 4.76B — -7,973.3% — — Current
ABBV Abbvie Inc $293.30 +0.68% 509.50B 49.3 6.9% +1.8% 4.47% Strong buy Compare
AMGN Amgen Inc $463.45 +0.66% 248.84B 26.5 21.0% +11.8% 3.21% Hold Compare
GILD Gilead Sciences Inc $169.25 +1.41% 208.28B — 28.9% +2.6% 3.98% Strong buy Compare
VRTX Vertex Pharmaceuticals Inc $549.39 +0.42% 137.12B 34.5 32.9% +10.4% — Strong buy Compare
MRNA Moderna Inc $276.88 +8.93% 105.54B — -145.2% -53.4% — Hold Compare
REGN Regeneron Pharmaceuticals $922.99 +2.06% 93.39B 19.4 31.4% +5.6% — Buy Compare
NTRA Natera Inc $317.32 +2.14% 45.18B — -9.0% +41.1% — Strong buy Compare
RVMD Revolution Medicines Inc $198.63 +3.30% 41.37B — 4.4% +0.4% — Strong buy Compare
BIIB Biogen Inc $259.80 +4.61% 36.60B 43.9 13.1% -0.9% — Buy Compare
ROIV Roivant Sciences Ltd $40.48 +4.12% 28.08B — -3,629.2% -48.7% — Strong buy Compare
UTHR United Therapeutics Corp $580.43 +3.28% 24.27B 18.5 41.9% +18.0% — Strong buy Compare
INCY Incyte Corp $119.65 +1.39% 24.22B 15.0 25.0% +14.8% — Hold Compare
INSM Insmed Inc $115.89 +1.30% 23.86B — -210.5% +35.2% — Strong buy Compare
ALNY Alnylam Pharmaceuticals Inc $156.52 +0.37% 20.98B 7.7 8.5% +53.0% — Strong buy Compare
EXAS Exact Sciences Corp $104.91 +0.95% 20.03B — -6.4% +15.9% — Hold Compare
EXEL Exelixis Inc $72.09 +3.62% 16.67B 18.8 33.7% +12.9% — Hold Compare
NBIX Neurocrine Biosciences Inc $168.19 +2.16% 16.41B 23.3 16.7% +24.3% — Strong buy Compare
BBIO Bridgebio Pharma Inc $77.42 +4.21% 14.51B — -144.4% +86.3% — Strong buy Compare
HALO Halozyme Therapeutics Inc $103.03 -0.58% 13.96B 33.7 22.7% +28.4% — Strong buy Compare
SMMT Summit Therapeutics Inc $17.86 +9.37% 12.69B — 15.4% -3.6% — Buy Compare